| Bioactivity | Doxazosin-d8 is a deuterium labeled Doxazosin (UK 33274). Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic α1 adrenergic receptors[1]. |
| Name | Doxazosin-d8 |
| CAS | 1126848-44-9 |
| Formula | C23H17D8N5O5 |
| Molar Mass | 459.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Miura, Y. and K. Yoshinaga, Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. Am Heart J, 1988. 116(6 Pt 2): p. 1785-9. |
Doxazosin-d8
CAS: 1126848-44-9 F: C23H17D8N5O5 W: 459.52
Doxazosin-d8 is a deuterium labeled Doxazosin (UK 33274). Doxazosin is a quinazoline-derivative that selectively antagon
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.